AJP - Cell Physiology, Vol 263, Issue 2 C294-C299, Copyright © 1992 by American Physiological Society

ARTICLES

Altered kinetics of AMP deaminase by myosin binding

K. W. Rundell, P. C. Tullson and R. L. Terjung
Department of Physiology, State University of New York Health Science Center, Syracuse.

AMP deaminase catalyzes the deamination of AMP to inosine 5'-monophosphate (IMP) and ammonia. Factors controlling the enzyme in muscle can rapidly promote high rates of IMP formation when ATP utilization exceeds supply. We evaluated whether binding of AMP deaminase to myosin, which occurs during intense contraction conditions, alters the kinetic behavior of the enzyme. Reaction kinetics of myosin-bound and free AMP deaminase were evaluated. Reaction kinetics of the free enzyme yielded a near-linear double-reciprocal plot with an expected Km of approximately 1 mM AMP concentration (AMP). In contrast, reaction kinetics of AMP deaminase became bimodal when bound to myosin. At [AMP] less than 0.15 mM, a high-affinity Km (0.05-0.10 mM) with maximal velocity approximately 20% that of free enzyme was evident. At [AMP] greater than 0.15 mM, the Km and maximal velocity values were similar to that of the free enzyme. The 10- to 20-fold higher affinity Km would allow for a higher rate of AMP deamination at the low [AMP] found physiologically. AMP deaminase binding to myosin also induced a marked resistance to orthophosphate inhibition (10 mM) in the presence of 50 microM ADP. Results were similar for purified preparations of AMP deaminase bound to myosin subfragment 2 and crude extracts obtained from contracting muscle. Our results add further support to the hypothesis that AMP deaminase binding to myosin serves an important role in control of enzyme activity in contracting muscle.

This article has been cited by other articles:

				G. B. Sala-Newby, N. V. E. Freeman, M. A. Curto, and A. C. Newby Metabolic and functional consequences of cytosolic 5'-nucleotidase-IA overexpression in neonatal rat cardiomyocytes Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H991 - H998. [Abstract] [Full Text] [PDF]

				T. Borza, C. V. Iancu, E. Pike, R. B. Honzatko, and H. J. Fromm Variations in the Response of Mouse Isozymes of Adenylosuccinate Synthetase to Inhibitors of Physiological Relevance J. Biol. Chem., February 21, 2003; 278(9): 6673 - 6679. [Abstract] [Full Text] [PDF]

				M. Gorselink, M. R. Drost, W. A. Coumans, G. P. J. van Kranenburg, R. P. Hesselink, and G. J. van der Vusse Impaired muscular contractile performance and adenine nucleotide handling in creatine kinase-deficient mice Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E619 - E625. [Abstract] [Full Text] [PDF]

				B. Sims, D. K. Mahnke-Zizelman, A. A. Profit, G. D. Prestwich, R. L. Sabina, and A. B. Theibert Regulation of AMP Deaminase by Phosphoinositides J. Biol. Chem., September 3, 1999; 274(36): 25701 - 25707. [Abstract] [Full Text] [PDF]

				D. K. Mahnke-Zizelman, P. C. Tullson, and R. L. Sabina Novel Aspects of Tetramer Assembly and N-terminal Domain Structure and Function Are Revealed by Recombinant Expression of Human AMP Deaminase Isoforms J. Biol. Chem., December 25, 1998; 273(52): 35118 - 35125. [Abstract] [Full Text] [PDF]

				I. Hisatome, T. Morisaki, H. Kamma, T. Sugama, H. Morisaki, A. Ohtahara, and E. W. Holmes Control of AMP deaminase 1 binding to myosin heavy chain Am J Physiol Cell Physiol, September 1, 1998; 275(3): C870 - C881. [Abstract] [Full Text] [PDF]

				J. W. E. Rush, P. C. Tullson, and R. L. Terjung Molecular and kinetic alterations of muscle AMP deaminase during chronic creatine depletion Am J Physiol Cell Physiol, February 1, 1998; 274(2): C465 - C471. [Abstract] [Full Text] [PDF]